Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.

Akaike K, Saruwatari K, Oda S, Shiraishi S, Takahashi H, Hamada S, Iyama S, Horio Y, Tomita Y, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Sakagami T.

Int J Clin Oncol. 2019 Nov 28. doi: 10.1007/s10147-019-01584-x. [Epub ahead of print]

PMID:
31781994
2.

Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells.

Tenjin Y, Nakamura K, Ishizuka S, Saruwatari K, Sato R, Tomita Y, Saeki S, Ichiyasu H, Fujii K, Ito T, Sakagami T.

Intern Med. 2019 Nov 15;58(22):3261-3265. doi: 10.2169/internalmedicine.2988-19. Epub 2019 Jul 10.

3.

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K, Ishizuka S, Sato N, Saruwatari K, Saeki S, Tomita Y, Sakagami T.

J Clin Med. 2019 May 29;8(6). pii: E762. doi: 10.3390/jcm8060762.

4.

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.

Hamada S, Ichiyasu H, Ikeda T, Inaba M, Kashiwabara K, Sadamatsu T, Sato N, Akaike K, Okabayashi H, Saruwatari K, Tomita Y, Saeki S, Hirata N, Yoshinaga T, Fujii K.

BMC Pulm Med. 2019 Apr 2;19(1):72. doi: 10.1186/s12890-019-0838-2.

5.

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.

Saruwatari K, Ikeda T, Saeki S, Shingu N, Imamura K, Komatu T, Ushijima S, Maruyama H, Kashiwabara K, Tomita Y, Ichiyasu H, Fujii K, Sakagami T.

Anticancer Res. 2019 Feb;39(2):923-931. doi: 10.21873/anticanres.13195.

PMID:
30711977
6.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

7.

[Basic Investigation of a Cerebral Blood Flow Quantification Method without Blood Sampling Method (Improved Brain Uptake Ratio (IBUR)) Using a Fan-beam Collimator].

Saruwatari K, Motomura N, Ito S, Uchiyama Y, Tanaka M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(11):1302-1312. doi: 10.6009/jjrt.2018_JSRT_74.11.1302. Japanese.

8.

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21.

9.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
10.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

11.

Theaflavin-3-gallate specifically interacts with phosphatidylcholine, forming a precipitate resistant against the detergent action of bile salt.

Narai-Kanayama A, Saruwatari K, Mori N, Nakayama T.

Biosci Biotechnol Biochem. 2018 Mar;82(3):466-475. doi: 10.1080/09168451.2017.1422967.

PMID:
29488451
12.

Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia.

Ichikawa T, Saruwatari K, Mimaki S, Sugano M, Aokage K, Kojima M, Hishida T, Fujii S, Yoshida J, Kuwata T, Ochiai A, Suzuki K, Tsuboi M, Goto K, Tsuchihara K, Ishii G.

Lung Cancer. 2017 Nov;113:134-139. doi: 10.1016/j.lungcan.2017.10.001. Epub 2017 Oct 5.

PMID:
29110840
13.

Neat monolayer tiling of molecularly thin two-dimensional materials in 1 min.

Matsuba K, Wang C, Saruwatari K, Uesusuki Y, Akatsuka K, Osada M, Ebina Y, Ma R, Sasaki T.

Sci Adv. 2017 Jun 30;3(6):e1700414. doi: 10.1126/sciadv.1700414. eCollection 2017 Jun.

14.

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody.

Tomita Y, Sueta D, Kakiuchi Y, Saeki S, Saruwatari K, Sakata S, Jodai T, Migiyama Y, Akaike K, Hirosako S, Fujisue K, Yamamura S, Miyazaki S, Takashio S, Izumiya Y, Nakamura K, Tsujita K, Ichiyasu H, Fujii K.

Ann Oncol. 2017 Nov 1;28(11):2893-2895. doi: 10.1093/annonc/mdx326. No abstract available.

PMID:
28651328
15.

Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy.

Saruwatari K, Umemura S, Nomura S, Kirita K, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Ohe Y, Goto K.

Clin Lung Cancer. 2016 Nov;17(6):581-587. doi: 10.1016/j.cllc.2016.05.022. Epub 2016 Jun 16.

PMID:
27424806
16.

The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.

Goto M, Naito M, Saruwatari K, Hisakane K, Kojima M, Fujii S, Kuwata T, Ochiai A, Nomura S, Aokage K, Hishida T, Yoshida J, Yokoi K, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):215-223. doi: 10.1007/s00432-016-2271-8. Epub 2016 Sep 17.

PMID:
27640003
17.

Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.

Naito M, Aokage K, Saruwatari K, Hisakane K, Miyoshi T, Hishida T, Yoshida J, Masato S, Kojima M, Kuwata T, Fujii S, Ochiai A, Sato Y, Tsuboi M, Ishii G.

Lung Cancer. 2016 Oct;100:53-62. doi: 10.1016/j.lungcan.2016.07.024. Epub 2016 Jul 27.

PMID:
27597281
18.

Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.

Saruwatari K, Ikemura S, Sekihara K, Kuwata T, Fujii S, Umemura S, Kirita K, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Ochiai A, Kohrogi H, Tsuboi M, Goto K, Ishii G.

Lung Cancer. 2016 Jan;91:7-14. doi: 10.1016/j.lungcan.2015.11.012. Epub 2015 Nov 15.

PMID:
26711928
19.

The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.

Sekihara K, Hishida T, Ikemura S, Saruwatari K, Morise M, Kuwata T, Fujii S, Kojima M, Ochiai A, Funai K, Aokage K, Yoshida J, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2016 May;142(5):905-12. doi: 10.1007/s00432-015-2098-8. Epub 2015 Dec 22.

PMID:
26696594
20.

Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.

Hisakane K, Saruwatari K, Fujii S, Kirita K, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, Ochiai A, Gemma A, Tsuboi M, Goto K, Ishii G.

J Cancer Res Clin Oncol. 2016 Mar;142(3):593-600. doi: 10.1007/s00432-015-2068-1. Epub 2015 Oct 31.

PMID:
26521256
21.

Rapid large-scale deployment of tuberculosis testing in a high school - Riverside County, California, 2013-2014.

Kaiser C, Cole B, Saruwatari K, Leon R; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):574-7.

22.

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.

Makinoshima H, Takita M, Saruwatari K, Umemura S, Obata Y, Ishii G, Matsumoto S, Sugiyama E, Ochiai A, Abe R, Goto K, Esumi H, Tsuchihara K.

J Biol Chem. 2015 Jul 10;290(28):17495-504. doi: 10.1074/jbc.M115.660498. Epub 2015 May 28.

23.

Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.

Sakata S, Sasaki J, Saeki S, Hamada A, Kishi H, Nakamura K, Tanaka H, Notsute D, Sato R, Saruwatari K, Iriki T, Akaike K, Fujii S, Hirosako S, Kohrogi H.

Oncology. 2015;88(4):201-7. doi: 10.1159/000369255. Epub 2014 Dec 6.

PMID:
25502447
24.

[Maintenance therapy for advanced non-small-cell lung cancer].

Saruwatari K, Yoh K.

Gan To Kagaku Ryoho. 2014 Aug;41(8):926-31. Review. Japanese.

PMID:
25132023
25.

Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK0803).

Yamada K, Takayama K, Kawakami S, Saruwatari K, Morinaga R, Harada T, Aragane N, Nagata S, Kishimoto J, Nakanishi Y, Ichinose Y.

Jpn J Clin Oncol. 2013 Jun;43(6):629-35. doi: 10.1093/jjco/hyt056. Epub 2013 Apr 18.

PMID:
23599349
26.

Case of Mycobacterium haemophilum infection in a Japanese renal transplant patient and a review of Japanese cases.

Takeo N, Hatano Y, Okamoto O, Saruwatari K, Nakanaga K, Ishii N, Yokoyama S, Fujiwara S.

J Dermatol. 2012 Nov;39(11):968-9. doi: 10.1111/j.1346-8138.2012.01533.x. Epub 2012 Mar 14. Review. No abstract available.

PMID:
22414269
27.

The presence of N(ε)-(Carboxymethyl) lysine in the human epidermis.

Kawabata K, Yoshikawa H, Saruwatari K, Akazawa Y, Inoue T, Kuze T, Sayo T, Uchida N, Sugiyama Y.

Biochim Biophys Acta. 2011 Oct;1814(10):1246-52. doi: 10.1016/j.bbapap.2011.06.006. Epub 2011 Jun 25.

PMID:
21708295
28.

Glycolytic intermediates induce amorphous calcium carbonate formation in crustaceans.

Sato A, Nagasaka S, Furihata K, Nagata S, Arai I, Saruwatari K, Kogure T, Sakuda S, Nagasawa H.

Nat Chem Biol. 2011 Apr;7(4):197-9. doi: 10.1038/nchembio.532. Epub 2011 Feb 20.

PMID:
21336282
29.

Morphological and crystallographic transformation from immature to mature coccoliths, Pleurochrysis carterae.

Saruwatari K, Nagasaka S, Ozaki N, Nagasawa H.

Mar Biotechnol (NY). 2011 Aug;13(4):801-9. doi: 10.1007/s10126-010-9342-7. Epub 2011 Jan 22.

PMID:
21258835
30.

Characterization of the multilayered shell of a limpet, Lottia kogamogai (Mollusca: Patellogastropoda), using SEM-EBSD and FIB-TEM techniques.

Suzuki M, Kameda J, Sasaki T, Saruwatari K, Nagasawa H, Kogure T.

J Struct Biol. 2010 Aug;171(2):223-30. doi: 10.1016/j.jsb.2010.04.008. Epub 2010 Apr 27.

PMID:
20430100
31.

Effect of coccolith polysaccharides isolated from the coccolithophorid, Emiliania huxleyi, on calcite crystal formation in in vitro CaCO3 crystallization.

Kayano K, Saruwatari K, Kogure T, Shiraiwa Y.

Mar Biotechnol (NY). 2011 Feb;13(1):83-92. doi: 10.1007/s10126-010-9272-4. Epub 2010 Mar 25.

PMID:
20336339
32.

An acidic matrix protein, Pif, is a key macromolecule for nacre formation.

Suzuki M, Saruwatari K, Kogure T, Yamamoto Y, Nishimura T, Kato T, Nagasawa H.

Science. 2009 Sep 11;325(5946):1388-90. doi: 10.1126/science.1173793. Epub 2009 Aug 13.

33.

Microtexture of larval shell of oyster, Crassostrea nippona: a FIB-TEM study.

Kudo M, Kameda J, Saruwatari K, Ozaki N, Okano K, Nagasawa H, Kogure T.

J Struct Biol. 2010 Jan;169(1):1-5. doi: 10.1016/j.jsb.2009.07.014. Epub 2009 Jul 16.

PMID:
19616099
34.

Nucleation and growth of aragonite crystals at the growth front of nacres in pearl oyster, Pinctada fucata.

Saruwatari K, Matsui T, Mukai H, Nagasawa H, Kogure T.

Biomaterials. 2009 Jun;30(16):3028-34. doi: 10.1016/j.biomaterials.2009.03.011. Epub 2009 Mar 28.

PMID:
19328543
35.

The proper ratio of GrpE to DnaK is important for protein quality control by the DnaK-DnaJ-GrpE chaperone system and for cell division.

Sugimoto S, Saruwatari K, Higashi C, Sonomoto K.

Microbiology. 2008 Jul;154(Pt 7):1876-85. doi: 10.1099/mic.0.2008/017376-0.

PMID:
18599817
36.

In vivo and in vitro complementation study comparing the function of DnaK chaperone systems from halophilic lactic acid bacterium Tetragenococcus halophilus and Escherichia coli.

Sugimoto S, Saruwatari K, Higashi C, Tsuruno K, Matsumoto S, Nakayama J, Sonomoto K.

Biosci Biotechnol Biochem. 2008 Mar;72(3):811-22. Epub 2008 Mar 7.

37.

A gram-negative characteristic segment in Escherichia coli DnaK is essential for the ATP-dependent cooperative function with the co-chaperones DnaJ and GrpE.

Sugimoto S, Higashi C, Saruwatari K, Nakayama J, Sonomoto K.

FEBS Lett. 2007 Jun 26;581(16):2993-9. Epub 2007 May 29.

38.

Humidity-sensitive electrical conductivity of a Langmuir-Blodgett film of titania nanosheets: surface modification as induced by light irradiation under humid conditions.

Saruwatari K, Sato H, Kogure T, Wakayama T, Iitake M, Akatsuka K, Haga M, Sasaki T, Yamagishi A.

Langmuir. 2006 Nov 21;22(24):10066-71.

PMID:
17107001
39.

Electron transfer through clay monolayer films fabricated by the Langmuir-Blodgett technique.

Yoshida J, Saruwatari K, Kameda J, Sato H, Yamagishi A, Sun L, Corriea M, Villemure G.

Langmuir. 2006 Nov 7;22(23):9591-7.

PMID:
17073484
40.

Photoconductive properties of organic-inorganic hybrid films of layered perovskite-type niobate.

Saruwatari K, Sato H, Idei T, Kameda J, Yamagishi A, Takagaki A, Domen K.

J Phys Chem B. 2005 Jun 30;109(25):12410-6.

PMID:
16852536
41.

Evidence for the role of organic layers in photoconductivity of organic/inorganic hybrid nanosheets as prepared by Langmuir-Blodgett methods.

Saruwatari K, Sato H, Kameda J, Yamagishi A, Domen K.

Chem Commun (Camb). 2005 Apr 21;(15):1999-2001. Epub 2005 Feb 21.

PMID:
15834485
42.

Estrogen regulation of nitric oxide synthesis in the porcine oocyte.

Hattori MA, Arai M, Saruwatari K, Kato Y.

Mol Cell Biochem. 2004 May;260(1-2):13-9.

PMID:
15228081
43.

H2 generation during dry grinding of kaolinite.

Kameda J, Saruwatari K, Tanaka H.

J Colloid Interface Sci. 2004 Jul 1;275(1):225-8.

PMID:
15158402
44.

Photoallergic contact dermatitis from mancozeb, an agricultural fungicide.

Higo A, Ohtake N, Saruwatari K, Kanzaki T.

Contact Dermatitis. 1996 Sep;35(3):183. No abstract available.

PMID:
8930488
45.

Photoallergic contact dermatitis due to Daconil.

Matsushita S, Kanekura T, Saruwatari K, Kanzaki T.

Contact Dermatitis. 1996 Aug;35(2):115-6. No abstract available.

PMID:
8917840
46.

Purification and properties of mycodextranase from Streptomyces sp. J-13-3.

Okazaki K, Abe T, Saruwatari K, Kato F, Maruyama K, Tagawa K.

Biosci Biotechnol Biochem. 1992 Sep;56(9):1401-5.

47.

[Surgery of pharynx and larynx and operative nursing care].

Matsuo K, Shin T, Saruwatari K.

Kango Gijutsu. 1984 Jan;30(2):192-7. Japanese. No abstract available.

PMID:
6560015
48.

Fulminating lactose-positive Vibrio septicemia.

Matsuo T, Kohno S, Ikeda T, Saruwatari K, Ninomiya H.

Acta Pathol Jpn. 1978 Nov;28(6):937-48.

PMID:
735824
49.

[Bacteria isolated from the blood - result in the last 6 years].

Mochida O, Kawawaki C, Iori F, Saruwatari K, Hayashi A.

Rinsho Byori. 1974 Oct;22(10 Suppl):339. Japanese. No abstract available.

PMID:
4475927
50.

[Sheep blood media for isolation of Haemophilus].

Saruwatari K, Saito A.

Rinsho Byori. 1971 Aug;19:Suppl:449. Japanese. No abstract available.

PMID:
5168130

Supplemental Content

Loading ...
Support Center